NZ580948A - Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof - Google Patents

Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof

Info

Publication number
NZ580948A
NZ580948A NZ580948A NZ58094808A NZ580948A NZ 580948 A NZ580948 A NZ 580948A NZ 580948 A NZ580948 A NZ 580948A NZ 58094808 A NZ58094808 A NZ 58094808A NZ 580948 A NZ580948 A NZ 580948A
Authority
NZ
New Zealand
Prior art keywords
methylpyrrolidine
methyl
tartrate
phenyl
pyrrolidin
Prior art date
Application number
NZ580948A
Other languages
English (en)
Inventor
Michael Christie
Joseph J Petraitis
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NZ580948A publication Critical patent/NZ580948A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
NZ580948A 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof NZ580948A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (1)

Publication Number Publication Date
NZ580948A true NZ580948A (en) 2011-04-29

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ580948A NZ580948A (en) 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof

Country Status (14)

Country Link
EP (1) EP2152669A1 (OSRAM)
JP (1) JP5698887B2 (OSRAM)
KR (1) KR20100017565A (OSRAM)
CN (1) CN101679237A (OSRAM)
AU (1) AU2008248168B2 (OSRAM)
BR (1) BRPI0810330A2 (OSRAM)
CA (1) CA2686033A1 (OSRAM)
EA (1) EA019031B1 (OSRAM)
IL (1) IL201627A (OSRAM)
MX (1) MX2009011787A (OSRAM)
NZ (1) NZ580948A (OSRAM)
UA (1) UA99913C2 (OSRAM)
WO (1) WO2008137087A1 (OSRAM)
ZA (1) ZA200907643B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2658821C (en) 2006-07-25 2014-10-21 Cephalon, Inc. Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2752406A1 (en) * 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
HK1244789B (en) * 2014-12-23 2019-12-06 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
AR116299A1 (es) * 2018-09-07 2021-04-21 Sanofi Sa Sales de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metilo y proceso de preparación de las mismas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CN100543050C (zh) 2004-03-08 2009-09-23 独立行政法人科学技术振兴机构 高分子担载金属簇组合物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
PL1755593T3 (pl) 2004-06-02 2008-06-30 Hoffmann La Roche Pochodne naftalenu przydatne jako ligandy 3-receptora histaminowego
WO2006059778A1 (ja) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
EP1831173B1 (en) 2004-12-17 2011-01-26 Janssen Pharmaceutica NV Tetrahydroisoquinoline compounds for treatment of cns disorders
CN101107231A (zh) 2005-01-21 2008-01-16 先灵公司 用作组胺h3拮抗剂的咪唑和苯并咪唑衍生物
EP1866293A1 (en) 2005-03-31 2007-12-19 UCB Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
US7943605B2 (en) 2005-10-27 2011-05-17 Ucb Pharma S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
ATE525072T1 (de) 2006-02-09 2011-10-15 Athersys Inc Pyrazole zur behandlung von adipositas und anderen zns-erkrankungen
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
WO2007105053A2 (en) 2006-03-13 2007-09-20 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
JP2009542673A (ja) 2006-06-29 2009-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド ヒスタミンh3−受容体関連障害の治療に有用なヒスタミンh3−受容体モジュレータ
CA2658821C (en) 2006-07-25 2014-10-21 Cephalon, Inc. Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors

Also Published As

Publication number Publication date
AU2008248168B2 (en) 2013-03-21
EA019031B1 (ru) 2013-12-30
KR20100017565A (ko) 2010-02-16
CA2686033A1 (en) 2008-11-13
MX2009011787A (es) 2009-11-13
JP2010526142A (ja) 2010-07-29
WO2008137087A1 (en) 2008-11-13
BRPI0810330A2 (pt) 2014-10-14
IL201627A0 (en) 2010-05-31
ZA200907643B (en) 2014-03-26
CN101679237A (zh) 2010-03-24
AU2008248168A1 (en) 2008-11-13
JP5698887B2 (ja) 2015-04-08
EA200971019A1 (ru) 2010-04-30
IL201627A (en) 2014-06-30
EP2152669A1 (en) 2010-02-17
UA99913C2 (ru) 2012-10-25

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
JP6117430B2 (ja) 選択的ヒストン脱アセチル化酵素抑制剤としての新規化合物およびこれを含む薬剤学的組成物
JP6392888B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての新規化合物およびこれを含む薬剤学的組成物
KR101799007B1 (ko) 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 설폰아마이드 유도체 화합물 및 이를 포함하는 약제학적 조성물
NL1032713C2 (nl) Histamine-3-receptorantagonisten.
CN111770918B (zh) Trpc6的抑制剂
ZA200603861B (en) Use of tricyclic compounds as glycine transport inhibitors
TW200403237A (en) New pyrrolidinium derivatives
AU2021308344B2 (en) Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
WO2000017163A1 (en) Cyanophenyl derivatives
NZ580948A (en) Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine derivatives and tartrate andor hydrochloride salts thereof
KR20230158007A (ko) 항바이러스 화합물
CN101583596A (zh) 作为组胺-3拮抗剂的n-经取代的氮杂环基胺
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
NZ511791A (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
WO2004029048A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
CN101142180B (zh) 作为组胺h3受体拮抗剂的吡咯烷衍生物
JP2010526142A5 (OSRAM)
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
AU2005252178B2 (en) Histamine H3 receptor agents, preparation and therapeutic uses
KR20230164136A (ko) Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
Vohra et al. Tertiary 3-aminopropenones and 3-aminopropenoates: Their preparation, with and without Lewis acids, from secondary amines and 1, 3-diketo compounds
AU2006316609A1 (en) Modulators of the H3 receptor useful for the treatment of disorders related thereto
RU2817736C1 (ru) Новые соединения в качестве ингибитора гистондеацетилазы 6 и фармацевтическая композиция, содержащая их

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed